D.E. Shaw & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-101,674
| Closed | -$15.4M | – | 4237 |
|
|
2022
Q3 | $15.4M | Sell |
101,674
-127,073
| -56% | -$19.2M | 0.02% | 685 |
|
|
2022
Q2 | $33.3M | Buy |
228,747
+221,116
| +2,898% | +$32.2M | 0.04% | 409 |
|
|
2022
Q1 | $905K | Sell |
7,631
-43,376
| -85% | -$5.14M | ﹤0.01% | 2934 |
|
|
2021
Q4 | $7.03M | Sell |
51,007
-69,703
| -58% | -$9.61M | 0.01% | 1402 |
|
|
2021
Q3 | $16.8M | Buy |
120,710
+72,656
| +151% | +$10.1M | 0.02% | 766 |
|
|
2021
Q2 | $4.67M | Sell |
48,054
-90,281
| -65% | -$8.76M | ﹤0.01% | 1490 |
|
|
2021
Q1 | $9.46M | Sell |
138,335
-25,174
| -15% | -$1.72M | 0.01% | 1036 |
|
|
2020
Q4 | $14M | Sell |
163,509
-16,388
| -9% | -$1.4M | 0.01% | 840 |
|
|
2020
Q3 | $11.7M | Buy |
179,897
+55,957
| +45% | +$3.64M | 0.01% | 830 |
|
|
2020
Q2 | $9.06M | Sell |
123,940
-14,957
| -11% | -$1.09M | 0.01% | 897 |
|
|
2020
Q1 | $4.73M | Buy |
138,897
+2,632
| +2% | +$89.6K | 0.01% | 1094 |
|
|
2019
Q4 | $7.42M | Sell |
136,265
-58,989
| -30% | -$3.21M | 0.01% | 984 |
|
|
2019
Q3 | $8.15M | Sell |
195,254
-41,662
| -18% | -$1.74M | 0.01% | 929 |
|
|
2019
Q2 | $10.4M | Buy |
236,916
+197,879
| +507% | +$8.66M | 0.01% | 843 |
|
|
2019
Q1 | $2.01M | Buy |
+39,037
| New | +$2.01M | ﹤0.01% | 1563 |
|